| 2025-11-13 |
详情>>
股本变动：
变动后总股本1372.13万股
|
| 2025-11-13 |
详情>>
业绩披露：
2026年中报每股收益-5.65美元,归母净利润-6366.2万美元,同比去年增长-85.35%
|
| 2025-11-13 |
财报披露：
美东时间 2025-11-13 盘后发布财报
|
| 2025-11-01 |
详情>>
内部人交易：
Meyrath Hugues等共交易3笔
|
| 2025-10-31 |
股东大会：
将于2025-12-16召开股东大会
会议内容 ▼▲
- 1.Elect Directors
2.Issuance of Senior Secured Convertible Notes
3.Issuance of Common Stock Under Forbearance Warrant Anti-Dilution Provisions
4.Amendment and Restatement of the 2023 Long-Term Incentive Plan
5.Non-Binding Advisory Vote on Executive Compensation
6.Ratification of Independent Auditors
7.Adjournment of the Annual Meeting
8.None as of the time this proxy statement was filed
|
| 2025-09-11 |
详情>>
业绩披露：
2026年一季报每股收益-1.87美元,归母净利润-1720.6万美元,同比去年增长17.36%
|
| 2025-08-26 |
详情>>
业绩披露：
2025年年报每股收益-22.35美元,归母净利润-1.15亿美元,同比去年增长-178.77%
|
| 2025-03-27 |
股东大会：
将于2025-04-24召开股东大会
会议内容 ▼▲
- 1.To approve the issuance of up to $200,000,000 of our common stock pursuant to a Standby Equity Purchase Agreement dated January 25, 2025 and related change of control for purposes of complying with Nasdaq listing rule 5635 (the “Nasdaq Proposal”);
2.To ratify the appointment of Grant Thornton LLP as our independent registered public accounting firm for our fiscal year ending March 31, 2026 (the “Ratification Proposal”);
3.To approve the adjournment of the Special Meeting to a later date, if necessary or appropriate (the “Adjournment Proposal”).
|
| 2025-02-12 |
详情>>
业绩披露：
2025年三季报(累计)每股收益-21.9美元,归母净利润-1.06亿美元,同比去年增长-373.46%
|
| 2024-12-19 |
复牌提示：
2024-12-18 14:01:47 停牌，复牌日期 2024-12-18 14:06:47
|
| 2024-11-14 |
详情>>
业绩披露：
2025年中报每股收益-7.17美元,归母净利润-3434.7万美元,同比去年增长-175.37%
|
| 2024-09-06 |
详情>>
业绩披露：
2024年中报每股收益-0.13美元,归母净利润-1247.3万美元,同比去年增长-50.22%
|
| 2024-09-06 |
详情>>
业绩披露：
2024年三季报(累计)每股收益-0.24美元,归母净利润-2234.2万美元,同比去年增长-172.8%
|
| 2024-08-27 |
详情>>
拆分方案：
每20.0000合并分成1.0000股
|
| 2024-08-14 |
详情>>
业绩披露：
2025年一季报每股收益-0.22美元,归母净利润-2082万美元,同比去年增长-127.74%
|
| 2024-08-14 |
详情>>
业绩披露：
2024年一季报每股收益-0.1美元,归母净利润-914.2万美元,同比去年增长13.83%
|
| 2024-07-02 |
股东大会：
将于2024-08-15召开股东大会
会议内容 ▼▲
- 1.Elect Directors
2.Approve Reverse Stock Split
3.Amend the 2023 Long-Term Incentive Plan
4.Non-Binding Advisory Vote on Executive Compensation
5.Ratify Grant Thornton LLP as Independent Auditors
6.Other Matters Properly Raised
|
| 2024-06-28 |
详情>>
业绩披露：
2023年年报每股收益-0.2美元,归母净利润-1836.8万美元,同比去年增长-147.89%
|
| 2024-06-28 |
详情>>
业绩披露：
2024年年报每股收益-0.43美元,归母净利润-4128.6万美元,同比去年增长-124.77%
|
| 2023-07-27 |
股东大会：
将于2023-09-12召开股东大会
会议内容 ▼▲
- 1.Election of Directors
2.Approval to Adopt the 2023 Long-Term Incentive Plan
3.Approval to Amend and Restate the Employee Stock Purchase Plan
4.Advisory Vote to Approve Executive Compensation
5.Advisory Vote on Frequency of Advisory Vote on Executive Compensation
6.Other Matters Properly Raised
|
| 2022-07-05 |
股东大会：
将于2022-08-16召开股东大会
会议内容 ▼▲
- 1.Election of Directors
2.Approval to Increase Authorized Shares
3.Advisory Vote to Approve Executive Compensation
4.Ratification of Armanino LLP as Independent Auditors
5.Other Matters Properly Raised
|
| 2021-09-06 |
温馨提示：
美股因劳工节，9月6日休市一天
|
| 2021-07-28 |
股东大会：
将于2021-09-21召开股东大会
会议内容 ▼▲
- 1.To elect five directors to serve until the 2022 annual meeting of stockholders or until their successors are elected and duly qualified;
2.To ratify the appointment of Armanino LLP as the independent registered public accounting firm of the Company for the fiscal year ending March 31, 2022;
3.To adopt a resolution approving, on an advisory basis, the compensation of the Company’s named executive officers;
4.To approve an amendment and restatement to the Company’s 2012 Long-Term Incentive Plan;
5.To transact such other business as may properly come before the Annual Meeting or any adjournment or postponement thereof.
|
| 2020-07-02 |
股东大会：
将于2020-08-18召开股东大会
会议内容 ▼▲
- 1.To elect five directors to serve until the next annual meeting of stockholders or until their successors are elected and duly qualified;
2.To ratify the appointment of Armanino LLP as the independent registered public accounting firm of the Company for the fiscal year ending March 31, 2021;
3.To adopt a resolution approving, on an advisory basis, the compensation of the Company’s named executive officers;
4.To transact such other business as may properly come before the meeting or any adjournment or postponement thereof.
|
| 2017-06-22 |
股东大会：
将于2017-08-23召开股东大会
会议内容 ▼▲
- 1.To elect seven directors to serve until the next annual meeting of stockholders or until their successors are elected and duly qualified;
2.To ratify the appointment of PricewaterhouseCoopers LLP as the independent registered public accounting firm of the Company for the fiscal year ending March 31, 2018;
3.To adopt a resolution approving, on an advisory basis, the compensation of the Company’s named executive officers;
4.To approve an amendment to the Company’s 2012 Long-Term Incentive Plan;
5.To approve and ratify an amendment to the Company’s Executive Officer Incentive Plan;
6.To adopt an amendment to the Company's Certificate of Incorporation to effect a reduction in the number of authorized shares of common stock;
7.To transact such other business as may properly come before the meeting or any adjournment or postponement thereof.
|
| 2017-02-22 |
股东大会：
将于2017-03-31召开股东大会
会议内容 ▼▲
- 1.To elect nine directors to serve until the next annual meeting of Stockholders or until their successors are elected and duly qualified;
2.To ratify the appointment of PricewaterhouseCoopers LLP as the independent registered public accounting firm of the Company for the fiscal year ending March 31, 2017;
3.To adopt a resolution approving, on an advisory basis, the compensation of the Company’s named executive officers;
4.To vote, on an advisory basis, on the frequency of future advisory votes on the compensation of the Company’s named executive officers;
5.To approve an amendment to the Company’s Employee Stock Purchase Plan to increase the number of shares available by 6,500,000;
6.To adopt an amendment to the Company’s Amended and Restated Certificate of Incorporation to effectuate a reverse stock split of our issued and outstanding shares of Common Stock at a ratio of between 1-for-3 and 1-for-8, inclusive, which ratio will be selected at the sole discretion of our Board of Directors at any whole number in the above range (the “Reverse Stock Split”), with cash paid for any fractional shares that would otherwise be issued as a result of the reverse stock split; provided, that our Board of Directors may abandon the Reverse Stock Split in its sole discretion;
7.To transact such other business as may properly come before the meeting or any adjournment or postponement thereof.
|